H. Kano-Hayashi

A hydroxymethylglutaryl coenzyme A reductase inhibitor improves endothelial function within 7 days in patients with chronic hemodialysis.

Toshio Hayashi, A. Iguchi, I. Sakuma, 2010, International journal of cardiology.

NADPH oxidase inhibitor, apocynin, restores the impaired endothelial‐dependent and ‐independent responses and scavenges superoxide anion in rats with type 2 diabetes complicated by NO dysfunction

Toshio Hayashi, A. Iguchi, T. Hayashi, 2005, Diabetes, obesity & metabolism.

A new HMG-CoA reductase inhibitor, pitavastatin remarkably retards the progression of high cholesterol induced atherosclerosis in rabbits.

L. Ignarro, Toshio Hayashi, A. Iguchi, 2004, Atherosclerosis.

Selective iNOS inhibitor, ONO1714 successfully retards the development of high-cholesterol diet induced atherosclerosis by novel mechanism.

Toshio Hayashi, A. Iguchi, D. Sumi, 2006, Atherosclerosis.

The treadmill exercise-tolerance test is useful for the prediction and prevention of ischemic coronary events in elderly diabetics.

Toshio Hayashi, A. Iguchi, T. Esaki, 2005, Journal of diabetes and its complications.